A medical recombinant collagen and its fermentation production method and application

Through the three-stage culture fermentation mode of Pichia yeast and magnetization induction treatment, combined with the flow velocity gradient feeding, the problem of insufficient methanol residue and antioxidant capacity is solved. The obtained recombinant collagen has good antioxidant capacity and is suitable for medical dressings. characteristic.

CN117535364BActive Publication Date: 2024-11-08GUANGZHOU YUEHUA MEDICAL TECH CO LTD
View PDF 14 Cites 0 Cited by

Patent Information

Application Number
CN202311474555.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-07
Publication Date
2024-11-08
Estimated Expiration
2043-11-07

AI Technical Summary

Technical Problem

The existing recombinant collagen fermentation methods are prone to residual methanol, which increases the methanol toxicity of downstream products and lacks antioxidant capacity.

Method used

The three-stage culture fermentation mode of Pichia yeast is adopted, combined with magnetization induction treatment and flow rate gradient feeding method, and through the regulation of magnetic field strength and time, methanol residues are reduced and antioxidant capacity is improved.

Benefits of technology

The obtained recombinant collagen has good antioxidant ability and is suitable for medical dressings, not absorbed by the epidermis, meets the requirements of Class II medical dressings, and improves production efficiency and cell density.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004536189510000071
    Figure BDA0004536189510000071
  • Figure HDA0004536189680000011
    Figure HDA0004536189680000011
Patent Text Reader

Abstract

The present invention proposes a medical recombinant collagen protein and a fermentation production method and application thereof, comprising taking Pichia pastoris GS115, inoculating it into an induction medium, performing a magnetization induction treatment, adding a methanol solution, performing a secondary magnetization induction treatment, inoculating the inoculum into an expansion medium, culturing, inoculating the expanded culture fluid into a fermentation medium, culturing, centrifuging, taking the supernatant, purifying and desalting, and obtaining the target recombinant collagen protein. The recombinant collagen protein purified by the present invention has good antioxidant capacity, and its scavenging rate for DPPH free radicals reaches 76%; the recombinant collagen protein can be applied to epidermal wound dressings, and it is not absorbed by the epidermis, meets the requirements for the application of Class II medical dressings, and can be used as medical recombinant collagen protein in medical dressings.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of collagen production, and in particular to a medical recombinant collagen and a fermentation production method and application thereof. Background Art

[0002] Collagen is a biopolymer and the main component of animal connective tissue. There are many types of collagen, and the common types are type I, type II, type III, type V and type XI. Collagen has good biocompatibility, biodegradability and biological activity, so it is widely used in food, medicine, tissue engineering, cosmetics and other fields. Through the research and development and breakthroughs of various technologies, recombinant collagen has expanded from the initial skin care products to medical devices, tissue engineering, health foods and other fields. At present, the application scope of recombinant collagen is gradually expanding, and the market demand for recombinant collagen and downstream products has also increased. Research data show that in 2022, the market size of recombinant collagen in my country will reach 18.5 billion yuan, a year-on-year increase of 71.3%. It is estimated that by 2027, the market size of recombinant collagen will reach 108.3 billion yuan. At present, my country's recombinant collagen industry has good development prospects.

[0003] At present, the existing fermentation method of recombinant collagen is to ferment it with Pichia pastoris, usually by adding methanol to induce Pichia pastoris expression, which easily leads to residual methanol in the recombinant collagen, increasing the methanol toxicity of the downstream products of the recombinant collagen. At the same time, the existing technology has little research on the antioxidant capacity of recombinant collagen obtained by Pichia pastoris induced fermentation. Summary of the invention

[0004] In view of this, the purpose of the present invention is to provide a medical recombinant collagen and a method and application of its fermentation production to solve the above problems.

[0005] The technical solution of the present invention is achieved in this way:

[0006] In one aspect, the present invention provides a fermentation production method of medical recombinant collagen, comprising the following steps:

[0007] S1 Take Pichia pastoris GS115, inoculate it into the induction medium at a rate of 1-2%, and culture it at 27-28°C for 15-20h to obtain a culture solution;

[0008] S2 takes the culture fluid, inoculates it into the expansion medium at a 1-2% inoculation amount, and cultures it at 27-28°C and 200-220 rpm for 40-55 hours to obtain the expansion culture fluid;

[0009] S3: inoculating the expanded culture fluid into the fermentation medium at a 4-5% inoculation amount, performing a primary magnetization induction treatment, adding a methanol solution, performing a secondary magnetization induction treatment, culturing at 27-28° C. for 20-25 hours, centrifuging, and taking the supernatant to obtain the supernatant containing the recombinant collagen;

[0010] S4 purifies and desalts the supernatant containing the recombinant collagen to obtain the target recombinant collagen.

[0011] A further solution is that the two magnetization induction treatments include: placing the fermentation medium in a magnetic field and performing magnetization treatment at a magnetic field strength of 100 to 150 mT for 20 to 60 minutes.

[0012] A further solution is that the magnetic field intensity of the first magnetization induction treatment is 150 mT, the magnetization treatment time is 20 min, and the magnetic field intensity of the second magnetization induction treatment is 100 mT, and the magnetization treatment time is 60 min.

[0013] In a further embodiment, the volume concentration of the methanol solution is 2-5%, and the amount of the methanol solution added to each 1L of the fermentation medium is 80-100mL.

[0014] A further solution is that each 1L of the induction medium includes the following components by weight: 0.8-1.2g yeast powder, 2.1-2.5g peptone, 2.1-2.5g glucose, 180-220μg acetylcarnosine and 0.8-1.2g mixed solution;

[0015] Each 1L of the expansion medium includes the following components by weight: 0.8-1.2g of yeast powder, 2.5-2.8g of peptone and 3-4g of glucose;

[0016] Each 1L of the fermentation medium includes the following components by weight: 0.8-1.2g of yeast powder, 2.1-2.5g of peptone, 2.1-2.5g of glucose and 0.8-1.2g of mixed solution;

[0017] The mixed solution comprises 0.8-1.2 g / L of ferrous sulfate heptahydrate, 0.2-2 g / L of zinc sulfate heptahydrate, 1.5-2.5 g / L of potassium dihydrogen phosphate, 0.2-0.5 g / L of manganese sulfate monohydrate and 0.05-0.08 g / L of biotin.

[0018] A further solution is that in step S3, the culturing for 20 to 50 hours also includes a first fermentation period of 6 to 10 hours, a middle fermentation period of 8 to 20 hours, and a last fermentation period of 6 to 20 hours.

[0019] During the first 6 to 10 hours of fermentation, the dissolved oxygen content of the fermentation liquid is maintained at 25 to 30%;

[0020] In the middle fermentation period of 8 to 20 hours, the dissolved oxygen content of the fermentation liquid is maintained at 35 to 40%, and fed-batch fermentation is started in a flow gradient manner, with glucose solution added at an initial rate of 5 to 6 mL / h / L, and the rate is increased gradually at 5 to 6 mL / h / L, and finally the flow rate is maintained at 25 to 28 mL / h / L, while acetylcarnosine is added;

[0021] In the latter 6 to 20 hours of the fermentation, the flow rate gradient is adjusted to a fermentation mode of constant feeding and discharging, and the glucose solution is fed at a rate of 12 to 15 mL / h / L. When the concentration of the glucose solution in the fermentation liquid is greater than 6 g / L, the discharging treatment is carried out. After the discharging treatment, the glucose solution is fed at a rate of 5 to 6 mL / h / L until the fermentation is completed.

[0022] A further solution is that in the middle fermentation period of 8.1 to 15 hours, the rate increases every 50 to 60 minutes; in the latter fermentation period of 15.1 to 25 hours, the volume of the discharge is 10 to 12% of the total volume of the fermentation liquid.

[0023] A further solution is that the concentration of acetylcarnosine added to the fermentation broth is 250-300 μg / L.

[0024] The present invention also provides medical recombinant collagen obtained by the above-mentioned fermentation production method of medical recombinant collagen.

[0025] In addition, the present invention further provides the use of the above-mentioned medical recombinant collagen in medical cosmetics. The medical recombinant collagen can be used as an antioxidant for scavenging DPPH free radicals and is used in medical cosmetics.

[0026] Compared with the prior art, the present invention has the following beneficial effects:

[0027] 1. The present invention sequentially performs magnetization induction treatment on the induction culture medium, expands the cultivation of the culture medium and adopts a three-stage culture and fermentation mode of the fermentation culture medium, combines the feeding method of the flow rate gradient with the fermentation mode of constant rate feeding and discharging, and regulates the fermentation parameters of each step, and the purified recombinant collagen has good antioxidant capacity; the recombinant collagen can be applied to epidermal wound dressings, is not absorbed by the epidermis, meets the requirements for the application of Class II medical dressings, and can be used as medical recombinant collagen in medical dressings.

[0028] 2. The present invention combines a one-time methanol magnetization induction treatment before the three-stage culture and fermentation mode of Pichia pastoris, which helps to improve the fermentation efficiency of Pichia pastoris. The addition of acetylcarnosine during the fermentation stage can reduce the toxic effects of intermediate metabolites and improve productivity and cell density.

[0029] 3. The process method for the fermentation induction culture of Pichia pastoris of the present invention is relatively simple, and a relatively ideal medical recombinant collagen can be achieved by controlling the fermentation mode, with a very small error tolerance, which is conducive to the control of production quality. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 This is an ultraviolet scanning image of the recombinant collagen prepared in Example 3 of the present invention. DETAILED DESCRIPTION

[0031] In order to better understand the technical content of the present invention, specific embodiments are provided below to further illustrate the present invention.

[0032] Unless otherwise specified, the experimental methods used in the embodiments of the present invention are all conventional methods.

[0033] Unless otherwise specified, the materials, reagents, etc. used in the embodiments of the present invention can be obtained from commercial sources.

[0034] Pichia pastoris GS115 was purchased from Invitrogen, USA.

[0035] Example 1 - Medium Composition

[0036] The components of each 1L induction medium are: 1.0g yeast powder, 2.2g peptone, 2.2g glucose, 200μg acetylcarnosine and 1.0g mixed solution;

[0037] The components of each 1L expansion medium are: 1.0g yeast powder, 2.7g peptone and 3.5g glucose;

[0038] The components of each 1L fermentation medium are: 1.0g yeast powder, 2.2g peptone, 2.2g glucose and 1.0g mixed solution;

[0039] The components of the mixed solution are as follows:

[0040] Components <![CDATA[FeSO4·7H2O]]> <![CDATA[ZnSO4·7H2O]]> <![CDATA[KH2PO4]]> <![CDATA[MnSO4·H2O]]> <![CDATA[V H ]]> Dosage g / L 1.0 1.2 2.0 0.35 0.07

[0041] Example 2 - Fermentation production method of medical recombinant collagen

[0042] Here are the steps:

[0043] S1 Take Pichia pastoris GS115, inoculate it into the induction medium at an inoculum of 1-2%, and culture it at a temperature of 27-28°C for 18 hours to obtain a culture solution;

[0044] S2 takes the culture fluid, inoculates it into the expansion medium at an inoculum of 1-2%, and performs shaking culture at a temperature of 27-28° C. and a shaking frequency of 200-220 rpm for 40-55 hours to obtain the expansion culture fluid;

[0045] S3 inoculates the expanded culture fluid into the fermentation medium at an inoculation rate of 4-5%, places the fermentation medium in a magnetic field, performs magnetization induction treatment at a magnetic field intensity of 150mT for 20min, reduces the magnetic field intensity to 100mT, performs long-term magnetization induction treatment for 60min, and avoids bacterial cell lysis and death due to too long time. After the magnetization induction treatment, at a temperature of 27-28°C, the fermentation culture is divided into three fermentation modes of the pre-fermentation stage, the middle fermentation stage and the post-fermentation stage. The fermentation mode of each stage is as follows:

[0046] Set 10h as the first stage of fermentation, and keep the dissolved oxygen content in the fermentation liquid at 25-30% through stirring and ventilation operations. Feeding can easily reduce the dissolved oxygen content, so no feeding operation is performed at this stage;

[0047] Then, 20h was set as the middle stage of fermentation. To compensate for the decrease in dissolved oxygen, the dissolved oxygen in the fermentation liquid was increased to 35-40% by stirring and ventilation. At the same time, fed-batch fermentation was started in a flow gradient manner. The glucose solution was fed at an initial rate of 5-6mL / h / L. The rate was increased every 60min, and the rate was increased gradually at a rate of 5-6mL / h / L. Finally, the flow rate of the glucose solution was kept in the range of 25-28mL / h / L. When the glucose solution was fed, a methanol solution with a volume concentration of 3% was fed at a constant rate, and the flow rate was 5-6mL / h / L.

[0048] Finally, 20h was set as the latter stage of fermentation, and the flow rate gradient of glucose was adjusted to a fermentation mode of constant feeding and discharging. Glucose solution was added at a rate of 12-15mL / h / L. When the concentration of glucose solution in the fermentation broth was >6g / L, discharging treatment was carried out, and the volume of the discharging was 10-12% of the total volume of the fermentation broth. After the discharging treatment, glucose solution was added at a rate of 5-6mL / h / L until the end of fermentation. Methanol solution with a volume concentration of 3% was added at a flow rate of 5-6mL / h / L until the end of fermentation.

[0049] After the fermentation is completed, the fermentation culture solution is centrifuged, and the supernatant is taken to obtain the supernatant containing the recombinant collagen;

[0050] S4 purifies and desalts the supernatant containing the recombinant collagen, and freeze-dries it to obtain the target recombinant collagen.

[0051] Example 3 - Fermentation production method of medical recombinant collagen

[0052] Here are the steps:

[0053] S1 Take Pichia pastoris GS115, inoculate it into the induction medium at an inoculum of 1-2%, and culture it at a temperature of 27-28°C for 18 hours to obtain a culture solution;

[0054] S2 takes the culture fluid, inoculates it into the expansion medium at an inoculum of 1-2%, and performs shaking culture at a temperature of 27-28° C. and a shaking frequency of 200-220 rpm for 45 hours to obtain the expansion culture fluid;

[0055] S3 inoculates the expanded culture fluid into the fermentation medium at an inoculation rate of 4-5%, places the fermentation medium in a magnetic field, performs magnetization induction treatment at a magnetic field strength of 150 mT for 20 minutes, adds 100 mL of a methanol solution with a volume concentration of 3% to each 1 L of the induction medium, reduces the magnetic field strength to 100 mT, performs a long-term magnetization induction treatment for 60 minutes, and avoids bacterial cell lysis and death due to too long a time. After the magnetization induction treatment, at a temperature of 27-28° C., the fermentation culture is divided into three fermentation modes of the pre-fermentation stage, the middle fermentation stage, and the post-fermentation stage. The fermentation mode of each stage is as follows:

[0056] Set 10h as the first stage of fermentation, and keep the dissolved oxygen content in the fermentation liquid at 25-30% through stirring and ventilation operations. Feeding can easily reduce the dissolved oxygen content, so no feeding operation is performed at this stage;

[0057] Then, 20h is set as the middle stage of fermentation. In order to compensate for the decrease of dissolved oxygen, the dissolved oxygen in the fermentation liquid is increased to 38-40% by stirring and ventilation operations. At the same time, fed-batch fermentation is started in a flow gradient manner. The glucose solution is fed at an initial rate of 5-6mL / h / L. The rate is increased every 60min, and the rate is increased gradually at a rate of 5-6mL / h / L. Finally, the flow rate of the glucose solution is maintained in the range of 25-28mL / h / L. When the glucose solution is fed, acetylcarnosine is fed until the concentration of acetylcarnosine in the fermentation liquid reaches the range of 250-300μg / L.

[0058] Finally, 20 h was set as the latter stage of fermentation, and the flow rate gradient was adjusted to a fermentation mode of constant feeding and discharging. Glucose solution was added at a rate of 12 to 15 mL / h / L. When the concentration of glucose solution in the fermentation broth was >6 g / L, discharging treatment was carried out, and the volume of the discharging was 10 to 12% of the total volume of the fermentation broth. After the discharging treatment, glucose solution was added at a rate of 5 to 6 mL / h / L until the end of fermentation.

[0059] After the fermentation is completed, the fermentation culture solution is centrifuged, and the supernatant is taken to obtain the supernatant containing the recombinant collagen;

[0060] S4 purifies and desalts the supernatant containing the recombinant collagen, and freeze-dries it to obtain the target recombinant collagen.

[0061] Depend on Figure 1It can be seen that in the ultraviolet scanning diagram, the target recombinant collagen of Example 3 has basically no absorption peak at 280nm, and there is no conjugated double bond inside the molecule. There is an absorption peak at 200-220nm, and there is a peptide bond.

[0062] Comparative Example 1-Fermentation production method of medical recombinant collagen

[0063] Here are the steps:

[0064] S1 Take Pichia pastoris GS115, inoculate it into the induction medium at an inoculum of 1-2%, and culture it at a temperature of 27-28°C for 18 hours to obtain a culture solution;

[0065] S2 takes the culture fluid, inoculates it into the expansion medium at an inoculum of 1-2%, and performs shaking culture at a temperature of 27-28° C. and a shaking frequency of 200-220 rpm for 45 hours to obtain the expansion culture fluid;

[0066] S3 inoculates the expanded culture fluid into the fermentation medium at an inoculum of 4-5%, and divides the fermentation culture into three stages of fermentation, namely, the pre-fermentation stage, the middle fermentation stage and the post-fermentation stage, at a temperature of 27-28°C. The fermentation mode of each stage is as follows:

[0067] Set 10h as the first stage of fermentation, and keep the dissolved oxygen content in the fermentation liquid at 25-30% through stirring and ventilation operations. Feeding can easily reduce the dissolved oxygen content, so no feeding operation is performed at this stage;

[0068] Then, 20h was set as the middle stage of fermentation. To compensate for the decrease in dissolved oxygen, the dissolved oxygen in the fermentation liquid was increased to 38-40% by stirring and ventilation. At the same time, fed-batch fermentation was started in a flow gradient manner. Glucose solution and 3% methanol solution were added at an initial rate of 5-6mL / h / L. The rate was increased every 60min, and the rate was increased gradually at a rate of 5-6mL / h / L, and finally the flow rate of the glucose solution was maintained in the range of 25-28mL / h / L.

[0069] Finally, 20 h was set as the latter stage of fermentation, and the flow rate gradient was adjusted to a fermentation mode of constant feeding and discharging. Glucose solution was added at a rate of 12-15 mL / h / L. When the concentration of glucose solution in the fermentation broth was >6 g / L, discharging treatment was carried out, and the volume of the discharging was 10-12% of the total volume of the fermentation broth. After the discharging treatment, glucose solution was added at a rate of 5-6 mL / h / L until the end of fermentation. Methanol solution with a volume concentration of 3% was added at a flow rate of 5-6 mL / h / L until the end of fermentation.

[0070] After the fermentation is completed, the fermentation culture solution is centrifuged, and the supernatant is taken to obtain the supernatant containing the recombinant collagen;

[0071] S4 purifies and desalts the supernatant containing the recombinant collagen, and freeze-dries it to obtain the target recombinant collagen.

[0072] Experimental Example 1-Antioxidant Analysis of Recombinant Collagen

[0073] (1) Scavenging effect on DPPH free radicals

[0074] Prepare a recombinant collagen sample with a mass concentration of 8.0 mg / mL, add 1 mL of sample to 1 mL of DPPH solution, mix quickly, and stand at room temperature in the dark for 30 minutes as the experimental group. Add 1 mL of sample to 1 mL of anhydrous ethanol solution as the blank group, and add 1 mL of DPPH solution to 1 mL of anhydrous ethanol solution as the control group. After standing for reaction, measure the absorbance value at 517 nm. The calculation formula is as follows:

[0075] The scavenging rate of DPPH free radical (%) = [(A0-A1+A2) / A0] × 100%, wherein A0 is the absorbance value of the control group, A1 is the absorbance value of the experimental group, and A2 is the absorbance value of the blank group.

[0076] (2) Antioxidant effects of recombinant collagen

[0077] The results of the scavenging effect of recombinant collagen on DPPH free radicals are shown in the following table:

[0078]

[0079] As can be seen from the above table, the recombinant collagen of Examples 2 and 3 has a certain scavenging ability for DPPH free radicals, and the scavenging rates reach 68% and 76%, indicating that the recombinant collagen purified by sequentially performing magnetization induction treatment on the induction medium, expanding the cultivation of the medium and the three-stage culture fermentation mode of the fermentation medium, combining the feeding mode of the flow rate gradient with the fermentation mode of constant rate feeding and discharging, and regulating the fermentation parameters of each step has good antioxidant capacity; compared with Example 3, the recombinant collagen obtained by multiple methanol induction in Example 2 has a reduced scavenging rate for DPPH free radicals, which also shows that the magnetization induction treatment combined with one-time methanol before the three-stage culture fermentation mode of Pichia pastoris is helpful to improve the fermentation efficiency of Pichia pastoris; compared with Example 3, the addition of acetylcarnosine in the fermentation stage can reduce the toxic effects of intermediate metabolites, improve productivity and cell density, avoid damage and destruction of mature bacteria, and reduce the fermentation efficiency.

[0080] Experimental Example 2-Transdermal Absorption Analysis of Recombinant Collagen

[0081] According to the "In vitro test method for skin absorption of chemicals" (GB / T 27818-2011), the transdermal absorption effect of recombinant collagen was tested. The intact abdominal skin of piglets was taken as an animal skin specimen. A scalpel was used to make a wound of about 4 mm in length on the animal skin specimen. The diffusion cell and the receiving cell used a phosphate buffer solution of pH 7.0. The test substance was the recombinant collagen of Example 3 with a mass concentration of 0.1%, 1% and 5%. After 24 hours of the test, the receiving solution was collected and the content of the recombinant collagen was detected by high performance liquid chromatography. The results are as follows:

[0082] project 0.1% 1% 5% Transdermal Amount - - -

[0083] Note: - indicates not detected

[0084] As can be seen from the table above, after 24 hours of transdermal absorption test, the recombinant collagen did not show transdermal absorption of the wound skin, and the content of recombinant collagen in the receiving fluid was not detected, indicating that the recombinant collagen can be used for epidermal wound dressings, and it is not absorbed by the epidermis, which meets the requirements for the application of Class II medical dressings, and can be used as medical recombinant collagen for medical dressings. It can be seen that the recombinant collagen purified by magnetization induction treatment of the induction medium, cultivation of the expansion medium and three-stage culture and fermentation mode of the fermentation medium, combined with the flow rate gradient feeding mode and the constant rate feeding and discharging fermentation mode, and regulating the fermentation parameters of each step can be used as medical recombinant collagen for medical dressings.

[0085] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A fermentation method for producing medical recombinant collagen, characterized in that: The steps include: S1 Take Pichia pastoris GS115, inoculate it into the induction medium at a rate of 1-2%, and culture it at 27-28°C for 15-20h to obtain the culture solution; Take the culture medium from S2, inoculate 1-2% of the inoculum into the expansion medium, and culture at 27-28°C and 200-220 rpm for 40-55 hours to obtain the expansion culture medium; S3 inoculates the expanded culture fluid into the fermentation medium at an inoculation rate of 4-5%, performs a magnetic induction treatment once, then adds a methanol solution, performs a secondary magnetic induction treatment, and divides the fermentation culture into three culture modes of the first fermentation stage of 6-10 hours, the middle fermentation stage of 8-20 hours, and the last fermentation stage of 6-20 hours at a temperature of 27-28°C, centrifuges, and takes the supernatant to obtain the supernatant containing the recombinant collagen; The magnetic field intensity of the first magnetization induction treatment was 150 mT, and the magnetization treatment time was 20 min. The magnetic field intensity of the second magnetization induction treatment was 100 mT, and the magnetization treatment time was 60 min. During the first 6 to 10 hours of fermentation, the dissolved oxygen content of the fermentation liquid is maintained at 25 to 30%; In the middle fermentation period of 8 to 20 hours, the dissolved oxygen content of the fermentation liquid is maintained at 35 to 40%, and fed-batch fermentation is started in a flow gradient manner, with glucose solution added at an initial rate of 5 to 6 mL / h / L, and the rate is increased by a gradient of 5 to 6 mL / h / L, and finally the flow rate is maintained at 25 to 28 mL / h / L, while acetylcarnosine is added; In the latter 6 to 20 hours of the fermentation, the flow rate gradient is adjusted to a fermentation mode of constant feeding and discharging, and the glucose solution is fed at a rate of 12 to 15 mL / h / L. When the concentration of the glucose solution in the fermentation broth is greater than 6 g / L, the discharging process is performed. After the discharging process, the glucose solution is fed at a rate of 5 to 6 mL / h / L until the fermentation is completed. Each 1L of the induction medium includes the following components by weight: 0.8-1.2 g of yeast powder, 2.1-2.5 g of peptone, 2.1-2.5 g of glucose, 180-220 µg of acetylcarnosine, and 0.8-1.2 g of a mixed solution; Each 1L of the expansion medium includes the following components by weight: 0.8-1.2 g of yeast powder, 2.5-2.8 g of peptone, and 3-4 g of glucose; Each 1L of the fermentation medium includes the following components by weight: 0.8-1.2 g of yeast powder, 2.1-2.5 g of peptone, 2.1-2.5 g of glucose and 0.8-1.2 g of mixed solution; The mixed solution includes 0.8-1.2 g / L of ferrous sulfate heptahydrate, 0.2-2 g / L of zinc sulfate heptahydrate, 1.5-2.5 g / L of potassium dihydrogen phosphate, 0.2-0.5 g / L of manganese sulfate monohydrate and 0.05-0.08 g / L of biotin; S4 purifies and desalts the supernatant containing the recombinant collagen to obtain the target recombinant collagen.

2. A fermentation method for producing medical recombinant collagen according to claim 1, characterized in that: The volume concentration of the methanol solution is 2-5%, and the amount of methanol solution added to each 1L of the fermentation medium is 80-100 mL.

3. A fermentation production method of medical recombinant collagen according to claim 1, characterized in that: The fermentation middle stage is 8.1-15 hours, and the rate increases every 50-60 minutes; the fermentation rear stage is 15.1-25 hours, and the volume of the discharge is 10-12% of the total volume of the fermentation liquid.

4. A fermentation method for producing medical recombinant collagen according to claim 1, characterized in that: The concentration of acetylcarnosine added to the fermentation broth is 250-300 µg / L.

5. A medical recombinant collagen obtained by the fermentation production method of a medical recombinant collagen according to any one of claims 1 to 4.

6. Use of the medical recombinant collagen according to claim 5 in medical cosmetics, characterized in that: The medical recombinant collagen is used as an antioxidant for removing DPPH free radicals.

Citation Information

Patent Citations

  • Preparation method of collagen

    CN107619845A

  • Mutagenesis method for collagenogenesis yeast on the basis of high-magnetic field gravity environment

    CN109536483A

  • Fermentation technology for improving production level of recombinant collagen

    CN113789358A

  • Process for improving fermentation level of recombinant collagen by adjusting concentration and addition mode of phosphoric acid

    CN116064706A

  • Pichia pastoris and culture method thereof

    CN116355766A